Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tranexamic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic hydrogenation method for tranexamic acid. Reduces catalyst poisoning, improves trans-isomer ratio, ensures supply chain stability for pharmaceutical intermediates.
Novel oxidation-ammonolysis method improves yield to 70%, reducing costs for pharmaceutical intermediates manufacturing and ensuring supply chain stability.
Novel enzyme-chemical hybrid process ensures high purity trans-tranexamic acid with reduced environmental impact and scalable manufacturing capabilities for global supply chains.
Patent CN103172528B details a high-efficiency tranexamic acid method. It offers significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel patent CN114436873B offers high-purity tranexamic acid manufacturing with reduced waste and enhanced supply chain reliability for global pharmaceutical partners seeking reliable suppliers.
Novel Diels-Alder route for high-purity tranexamic acid. Reduces heavy metal residues and improves yield for API manufacturing.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.